Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess Safety, Tolerability, Pharacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years

Project: Research

Project Details

StatusFinished
Effective start/end date01/29/16 → 07/1/18

Funding

  • Novo Nordisk Incorporated: $66,827.00